Coconut oil attenuates the effects of amyloid-β on cortical neurons in vitro

Journal of Alzheimer's Disease

Volumn 39, Issue 2, 2014, Pages 233-237

  Nafar, Firoozeh ^a   Mearow, Karen M ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Amyloid; Coconut oil; cortical neurons

Indexed keywords

AMYLOID BETA PROTEIN; COCONUT OIL;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; IN VITRO STUDY; MITOCHONDRION; MOLECULAR MECHANICS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID; COCONUT OIL; CORTICAL NEURONS;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; NEURONS; NOOTROPIC AGENTS; PILOT PROJECTS; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84893912020     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131436     Document Type: Article

References (23)

1. Liau KM, Lee YY, Chen CK, Rasool AH (2011) An openlabel pilot study to assess the efficacy and safety of virgin coconut oil in reducing visceral adiposity. ISRN Pharmacol 2011, 949686.
2. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC (2009) Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease:Arandomized, doubleblind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 6, 31.
3. DeDea L (2012) Can coconut oil replace caprylidene for Alzheimer disease? JAAPA 25, 19.
4. Henderson ST (2008) Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics 5, 470-480.
5. Maalouf M, Rho JM,MattsonMP(2009) The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 59, 293-315.
6. Balietti M, Casoli T, Di Stefano G, Giorgetti B, Aicardi G, Fattoretti P (2010) Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain. Ageing Res Rev 9, 273-279.
7. Kashiwaya Y, Bergman C, Lee JH,Wan R, King MT,Mughal MR, Okun E, Clarke K, Mattson MP, Veech RL (2013) A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 34, 1530-1539.
8. Balietti M, Giorgetti B, Di Stefano G, Casoli T, Platano D, Solazzi M, Bertoni-Freddari C, Aicardi G, Lattanzio F, Fattoretti P (2010) A ketogenic diet increases succinic dehydrogenase (SDH) activity and recovers age-related decrease in numeric density of SDH-positive mitochondria in cerebellar Purkinje cells of late-adult rats. Micron 41, 143-148.
9. Studzinski CM, MacKay WA, Beckett TL, Henderson ST, Murphy MP, Sullivan PG, Burnham WM (2008) Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog. Brain Res 1226, 209-217.
10. Freeman LR, Granholm AC (2012) Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. J Cereb Blood Flow Metab 32, 643-653.
11. Granholm AC, Bimonte-Nelson HA, Moore AB, Nelson ME, Freeman LR, Sambamurti K (2008) Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis 14, 133-145.
12. King M, Nafar F, Clarke J, Mearow K (2009) The small heat shock protein Hsp27 protects cortical neurons against the toxic effects of beta-amyloid peptide. J Neurosci Res 87, 3161-3175.
13. Group A (2012) ALSUntangled 15: Coconut Oil. Amyotroph Lateral Scler 13, 328-330.
14. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29, 9090-9103.
15. Calkins MJ, Reddy PH (2011) Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim Biophys Acta 1812, 507-513.
16. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107, 18670-18675.
17. Duboff B, FeanyM, Gotz J (2013) Why size matters-balancing mitochondrial dynamics in Alzheimer's disease. Trends Neurosci 36, 325-335.
18. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105, 19318-19323.
19. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL (2000) D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci U S A 97, 5440-5444.
20. Wlaz P, Socala K, Nieoczym D, Luszczki JJ, Zarnowska I, Zarnowski T, Czuczwar SJ, Gasior M (2012) Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice. Neuropharmacology 62, 1882-1889.
21. Spector R (1988) Fatty acid transport through the blood-brain barrier. J Neurochem 50, 639-643.
22. Guzman M, Blazquez C (2001) Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab 12, 169-173.
23. Guzman M, Blazquez C (2004) Ketone body synthesis in the brain: Possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 70, 287-292.